Kiovig 30 g/300 mL (human normal immunoglobulin 10%) solution for infusion, 1 vial — original (Takeda) Primary immunodeficiency syndrome. Delivery of medications from Europe within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.

Replacement therapy in adults, children and children (age 0–18 years) in the following conditions:

• primary immunodeficiency syndrome (PID) with impaired antibody synthesis (division “Peculiarities” zastosuvannya");
• secondary immunodeficiency (SID) in patients with severe or recurrent infections, ineffective antimicrobial treatments,insufficient specific antibodies (DNSA)* or level of IgG in serum < 4 g/l.

*DNSA - Unavailability of increasing the titer of IgG antibodies before the pneumococcal polysaccharide and polypeptide vaccine at least twice antigen.

Immunomodulation in adults, children and children (age 0–18 years) in the following conditions:

• primary immune thrombocytopenia (PIT) in patients with a high risk of bleeding or before surgical treatment with a method of correction of the platelet count;
• Guyenne's syndrome? Barre;
• Kawasaki disease (for the combination with acetylsalicylic acid, section “Method of administration and dosage”);
• chronic inflammatory demyelinating polyradiculoneuropathy (CDDP);
• Multifocal motor neuropathy (MFN).